Investing Profile

Raphael Wisniewski

InvestorVC
Associate at Andera Partners
Photo of Raphael Wisniewski, Associate at Andera Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Andera Partners Associate
$5.0M - $35.0M
$20.0M
19
CompanyStageDateRound SizeTotal Raised
Exciva
Series BJan 2026$59M
Series AOct 2021$10M
$69M
Co-investors: Sofia Ioannidou (Andera Partners)
Spiro Medical
Series AJan 2026$67M
$67M
Artios Pharma
Series DNov 2025$120M
Series CJul 2021$150M
Series BAug 2018$83M
$380M
Co-investors: Hakan Goker (M Ventures (Merck)), Florian Müllershausen (Novartis Venture Fund), Barbara Dalton (Pfizer Venture Investments), Nikola Trbovic (Pfizer Venture Investments), Jake Simson (RA Capital)
EG 427
Series BFeb 2025$28M
$28M
ENYO Pharma
Series CJan 2024$28M
Series BJun 2018$47M
$75M
Co-investors: Carl Gordon (OrbiMed), Iain Dukes (OrbiMed)
BioVentrix
Series AApr 2023$49M
$49M
SoniVie
Series CJan 2023$60M
$60M
Amolyt Pharma
Series CJan 2023$140M
$290M
Co-investors: Ohad Hammer (Pontifax Venture Capital), Thierry Laugel (Kurma Partners), Iyona Rajkomar (Pontifax Venture Capital)